New triple-action diabetes jab delivers impressive blood sugar and weight-loss results A new triple hormone receptor agonist for type 2 diabetes could lower blood pressure and body weight. The clinical results achieved after 40 weeks showed that patients taking weekly retatrutide injections. ..



